In contrast, PRSS23 knockdown reduced proliferation and increased anoikis sensitivity in high-grade serous and clear cell ovarian carcinoma cell lines and diminished tumor establishment, dissemination, and ascites in intraperitoneal xenograft models. Here, PRSS23 is linked to neoplasm.